학술논문
Atezolizumab (atezo) + platinum/gemcitabine (plt/gem) vs placebo + plt/gem for first-line (1L) treatment (tx) of locally advanced or metastatic urothelial carcinoma (mUC): Final OS from the randomized Phase 3 IMvigor130 study.
Document Type
Article
Author
Galsky, Matt D.; Arranz Arija, Jose Angel; De Santis, Maria; Davis, Ian D.; Bamias, Aristotelis; Kikuchi, Eiji; Garcia del Muro, Xavier; Park, Se Hoon; De Giorgi, Ugo; Alekseev, Boris; Mencinger, Marina; Izumi, Kouji; Puente, Javier; Li, Jian-Ri; O'Donnell, Peter H.; Bernhard, Sandrine; Lee, Chooi Peng; Bene-Tchaleu, Fabiola; Mariathasan, Sanjeev; Grande, Enrique
Source
Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, pLBA440-LBA440, 1p
Subject
Language
ISSN
0732183X